SINGLETON J MATTHEW 4
4 · Viking Therapeutics, Inc. · Filed Oct 25, 2024
Insider Transaction Report
Form 4
SINGLETON J MATTHEW
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.00001 per share
2024-10-25$4.48/sh+16,000$71,680→ 25,500 total - Sale
Common Stock, par value $0.00001 per share
2024-10-25$79.50/sh−16,000$1,272,000→ 9,500 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-25−16,000→ 0 totalExercise: $4.48From: 2019-01-02Exp: 2028-01-02→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 16, 2024 by the Reporting Person.